Gaps and roadmap of novel neuromodulation targets for treatment of gait in Parkinson’s disease

Abstract Gait issues in Parkinson’s disease (PD) are common and can be highly disabling. Although levodopa and deep brain stimulation (DBS) of the subthalamic nucleus and the globus pallidus internus have been established therapies for addressing the motor symptoms of PD, their effects on gait are l...

Full description

Bibliographic Details
Main Authors: Rubens Gisbert Cury, Nicola Pavese, Tipu Z. Aziz, Joachim K. Krauss, Elena Moro, the Neuromodulation of Gait Study Group from Movement Disorders Society
Format: Article
Language:English
Published: Nature Portfolio 2022-01-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-021-00276-6

Similar Items